MARC FELDMANN FESTSCHRIFT: FROM THE LABORATORY TO THE CLINIC: CYTOKINES, AUTOIMMUNITY AND IMMUNOTHERAPY
University of Oxford’s Museum of Natural History and Trinity College, Oxford
WEDNESDAY 2nd SEPTEMBER
SESSION 1.
CYTOKINES/MATRIX
THURSDAY 3rd SEPTEMBER
SESSION 2.
IMMUNITY/AUTOIMMUNITY
FRIDAY 4th SEPTEMBER
SESSION 3.
THERAPEUTICS
9.00
REGISTRATION at Natural History Museum
SESSION 1A: Chair:
SESSION 2A: Chair:
9.00
Anne Cooke
Analysing type I diabetes
9.30
Larry Steinman
Antigen specific tolerance for certain autoimmune
diseases - diabetes, neuromyelitis optica- and
after gene therapy
10.00
Mark Davis
Concerted T cell activity in autoimmunity and reading the
alpha beta TCR repertoire
10.30
Dan Littman
SESSION 3A: Chair:
9.00
Bali Pulendran
Systems based approach to vaccine design
9.30
Tracy Hussell
Discovery of new therapeutic targets for acute and
chronic airway disease.
11.00
Tea/coffee break
SESSION 2B: Chair:
11.30
Anne O’Garra
The use of transcriptomics to uncover the immune
response to pathogens: from mouse models to human
disease
12.00
Irina Udalova
Myeloid cells in acute and chronic inflammation: search
for novel therapeutics
12.30
Jeff Ravetch
Structural and functional diversity of immunoglobulin
Fc and its receptors
1.00
LUNCH
SESSION 2C: Chair:
2.00
Mike Dustin
New interactions in the immunological synapse
2.30
Vanda Lennon
Neuromyelitis optica: an IgG-mediated inflammatory
synapthopathy targeting astrocytes
3.00
Tada Taniguchi
Regulation of inflammation and innate immunity by
self-derived molecules
3.30
Tea/coffee break
SESSION 2D: Chair:
4.00
Kasia Hawrylowicz
Immune mechanisms by which vitamin D promotes
respiratory health
4.30.
Tak Mak
Beyond immune checkpoint blockade:
emerging strategies
5.00
Alain Fischer
The human immune system viewed from its inherited
defaults
11.00
Tea/coffee break
SESSION 3B: Chair:
11.30
Carl June
9.30
Richard Flavell
10.00
Jagdeep Nanchahal
From the lab to the clinic for localised fibrosis
10.30
Mike Brennner
Targeting fibroblasts to treat rheumatoid
arthritis and type II diabetes
11.00
Tea/coffee break
SESSION 1B: Chair:
11.30
Kim Midwood
The extracellular matrix: a pro-inflammatory microenvironment during tissue injury and infection
12.00
12.30
Nicole Horwood
Cells of the innate immune system in entheseal bone
formation
Eddy Liew
IL-33
1.00
LUNCH
SESSION 1C: Chair: Joost Oppenheim
2.00
Claudia Monaco
2.30
Tonia Vincent
Sequestered molecules of the pericellular matrix; their role
in sterile injury and disease
3.00
Martin Turner
Regulation of lymphocyte development and
activation by RNA binding proteins
3.30
Tea/coffee break
SESSION 1D: Chair:
4.00
Vijay Kuchroo
Identification of lymphocyte development and activation
by RNA binding proteins
4.30
Paul Bowness
Type-17 immunity in Ankylosing Spondylitis
5.00
Andreas Radbruch
A pathogenic immunological memory can drive chronic
inflammation
10.00
10.30
Mike Shepard
Breaching the castle walls: Hyaluronan-Depletion as a
therapeutic approach to cancer therapy
Andrew McMichael
HIV vaccine design for prevention and therapy
12.00
Miriam Merad
Myeloid cell control of tissue inflammation
12.30
Andy Cope
“Less of your Lyp” is not such a good thing
1.00
LUNCH
SESSION 3C: Chair:
2.00
Greg Winter
Antibody technologies
2.30
John O’Shea
3.00
Chris Buckley
Why does chronic inflammation persist: a key role for
the stroma?
3.30
Tea/coffee break
SESSION 3D: Chair:
4.00
Lars Klareskog
Understanding of specificity of adaptive immunity in
RA reveals new targets for therapy
4.30
Ashok Venkitaraman